Notably, patients with obesity or diabetes have lower plasma apoA5 levels compared with the healthy controls, and experimentally-induced hyperinsulinemia also reduced plasma APOA5 levels in healthy men [36]. This evidence concerns the gene APOA5 and obesity due to melanocortin 4 receptor deficiency.